[Effect of amlodipine on intravascular thrombocyte activity in patients with arterial hypertension and metabolic syndrome].
In order to evaluate therapeutic effects of amlodipine on intravascular thrombocyte activity (ITA) in patients having arterial hypertension (AH) with metabolic syndrome (MS), 20 patients were treated with amlodipine for 1 month. The researchers monitored changes in anthropometric indices, blood lipid spectrum, lipid peroxidation in serum and thrombocytes, anti-oxidant protectability of platelets and the liquid part of blood and ITA. Amlodipine application in patients having AH with MS reduced peroxidation syndrome and optimized thrombocyte aggregation. Long-term administration of amlodipine stabilizes the achieved effect. To lower body weight in patients having AH with MS administration of amlodipine should be combined with use of non-drug means.